September 16-17: Meet us at Antibody-Drug Conjugates Symposium 2026
Date
September 3rd, 2026APC and VLE Therapeutics will be presenting "Development of a Platform Approach for Continuous ADC Conjugation Process Manufacturing" at the Antibody-Drug Conjugates Symposium, Prague.
If you're planning on attending, we’d love to meet one-on-one to discuss your development and manufacturing challenges and our approach to accelerating your medicines through CMC hurdles.
Schedule a meeting to discuss your project below!
What sets APC & VLE Therapeutics apart:
Best-in-class Science: Advancing the boundaries of pharmaceutical process research and development through a world class team of scientific experts.
First-in-class Digital: Accelerating medicine development and manufacturing outcomes through the application of our state-of-the-art digital technologies.
Science-First Manufacturing: Driving manufacturing outcomes through industry-first scientific and digitalization breakthroughs.